近日，东安格利亚大学研究人员通过血液稀释剂对人体艾滋病毒天然屏障有了新了解。
新研究揭示了朗格汉斯蛋白如何作为感染艾滋病毒阶段的自然屏障存在于生殖器分泌液中，期间与药物肝素相互作用。
研究小组已经鉴定了朗格汉斯蛋白和肝素之间不同机制的相互作用。东安格利亚大学药学学院博士研究员Jesus Angulo说：“朗格汉斯蛋白存在于生殖器粘液中并由免疫细胞产生。艾滋病病毒在感染人的过程中朗格汉斯蛋白组成了道屏障。肝素是一种抗凝剂，用来防止血栓的形成。但它也在体内自然生成，并且带有不同成分包绕着我们的细胞。”

“朗格汉斯蛋白与肝素的交互作用对hiv病毒退化来说是非常重要的。肝素与朗格汉斯蛋白交互的方式很重要，因为它被认为可以稳定颗粒的形成，有利于消除艾滋病毒颗粒。”
“这是一个基本的研究，该研究提供了一个已知HIV天然屏障潜在交互作用的细节结构。然而，这并不意味着服用肝素或其他抗凝药物会保护人们免受艾滋病毒的侵扰。”
“这一研究的*终目的是开发抑制促感染艾滋病毒细胞受体的药物，该药并能促进朗格汉斯蛋白活性。抗艾滋药物的研制显然是一个长期目标，而该研究提供了重要的制药初始步骤。”

原文链接：Langerin–Heparin Interaction: Two Binding Sites for Small ａnd Large Ligands As Revealed by a Combination of NMR Spectroscopy ａnd Cross-Linking Mapping Experiments

Langerin is a C-type lectin present on Langerhans cells that mediates capture of pathogens in a carbohydrate-dependent manner, leading to subsequent internalization ａnd elimination in the cellular organelles called Birbeck granules. This mechanism mediated by langerin was shown to constitute a natural barrier for HIV-1 particle transmission. Besides interactingspecifically with high mannose ａnd fucosylated neutral carbohydrate structures, langerin has the ability to bind sulfated carbohydrate ligands as 6-sulfated galactosides in the Ca2+-dependent binding site. Very recently langerin was demonstrated to interact with sulfated glycosaminoglycans （GAGs）, in a Ca2+-independent way, resulting in the proposal of a newbinding site for GAGs. On the basis of those results, we have conducted a structural study of the interactions of small heparin （HEP）-like oligosaccharides with langerin in solution.Heparin bead cross-linking experiments, an approach specifically designed to identify HEP/heparan sulfate binding sites in proteins were first carried out ａnd experimentally validated the previously proposed model for the interaction of langerin extracellular domain with 6 kDa HEP. High-resolution NMR studies of a set of eight synthetic HEP-like trisaccharides harboring different sulfation patterns demonstrated that all of them bound tolangerin in a Ca2+-dependent way. The binding epitopes were determined by saturation transfer difference NMR ａnd the bound conformations by transferred NOESY experiments. These experimental data were combined with docking and molecular dynamics ａnd resulted in the proposal of a binding mode characterized by the coordination of calcium by the twoequatorial hydroxyl groups, OH3 ａnd OH4, at the non-reducing end. The binding also includes the carboxylate group at the adjacent iduronate residue. This epitope is shared by all eight ligands, explaining the absence of any impact on binding from differences in their substitution patterns. Finally, in contrast to the small trisaccharides, we demonstrated that a longer HEP-like hexasaccharide, bearing an additional O-sulfate group at the non-reducing end, which precludes binding to the Ca2+ site, interacts with langerin in the previously identified Ca2+-independent binding site.